The Food and Drug Administration has approved a new drug, Cobenfy, for schizophrenia that is said to have fewer side effects than current medications. This has been a major development for patients like Tiffany who have struggled with severe side effects from traditional antipsychotic drugs. Tiffany shares her personal experience and how this new medication gives her hope for a better quality of life.